Gemcitabine administered as a short infusion versus a fixed dose rate in combination with cisplatin for the treatment of patients with advanced non-small cell lung cancerJosé Rodrigues Pereira, Maximiliano Van Kooten, Luis Fein et al.|Lung Cancer|2007Cited by 11
Multicenter, randomized trial comparing a combined gemcitabine and cisplatin 3-week regimen with a 4-week regimen in non-small cell lung cancer (NSCLC) patientsM. Liao, L. Wang, Shaoqing Yu et al.|Journal of Clinical Oncology|2006Cited by 0